Skip to main content
Today · Plain-English health journalism — fact-checked, ad-free, and free for everyone. · Every claim cited to the evidence.
Supplements

The Calcium and Vitamin D Rethink: What 69 Trials Now Show

A BMJ meta-analysis of 153,902 older adults finds that routine calcium and vitamin D supplements offer little meaningful protection against fractures or falls — here's what the evidence actually supports.

Share: 𝕏 f in
A 2026 BMJ meta-analysis of 69 RCTs found routine calcium and vitamin D supplements do not meaningfully reduce fractures or falls in healthy older adu

The 60-second version

A 2026 BMJ meta-analysis pooling 69 randomised controlled trials and 153,902 older adults found that calcium alone, vitamin D alone, or their combination produced little to no clinically meaningful reduction in fracture rates or falls in community-dwelling adults Massé 2026. The finding challenges advice that has been standard in primary care for at least 30 years, suggesting that most healthy older people living independently do not benefit from routine supplementation. The evidence does not mean vitamin D and calcium are unimportant — dietary adequacy still matters, and certain high-risk groups (frail older adults, those in residential care, people with confirmed deficiency) may still benefit from targeted supplementation.

For decades, a bottle of calcium carbonate and a vitamin D capsule sitting on the kitchen counter felt like sensible medicine — until a landmark meta-analysis published in June 2026 quietly upended that assumption for most of us.

Educational journalism, not medical advice. Every claim here is checked against its cited sources by editor Tim Bunce — a health writer, not a physician. It isn’t specific to your situation: for health decisions, talk to your own clinician. How we work →

What the researchers actually did

Massé and colleagues conducted a pre-registered systematic review and meta-analysis of randomised controlled trials comparing calcium supplementation, vitamin D supplementation, or the combination against placebo or no treatment in adults aged 50 and older Massé 2026. Their final dataset included 69 RCTs enrolling 153,902 participants — one of the largest fracture-and-falls evidence syntheses ever assembled.

The primary outcomes were fractures of any type (hip, vertebral, non-vertebral, total) and falls. Secondary outcomes included adverse events such as kidney stones and hypercalcaemia, which are known concerns with long-term calcium supplementation. The team used GRADE methodology to rate the certainty of their findings, which allows readers to distinguish between a finding that is moderately well-established and one that is nearly definitive.

Crucially, the review focused heavily on community-dwelling older adults — people living in their own homes, as opposed to nursing-home residents or hospital inpatients. That distinction matters enormously for how to interpret the results.

What the numbers actually showed

Did supplements reduce fractures?

For hip fracture — the outcome that matters most clinically, because hip fractures carry a one-year mortality rate of approximately 20–30% in older adultsAbrahamsen 2009 — neither calcium alone, vitamin D alone, nor the combination produced a statistically or clinically meaningful reduction in community-dwelling populations Massé 2026.

For total fractures and non-vertebral fractures, the pooled effect sizes were similarly negligible in the community-dwelling subgroup, with confidence intervals that consistently crossed the null. The certainty of evidence for these null findings was rated as moderate to high by GRADE standards, meaning the result is unlikely to change substantially with future trials in this population.

Did supplements reduce falls?

Falls — which cause approximately 95% of hip fracturesParkkari 1999 — were also not meaningfully reduced by any of the three supplementation strategies in community-dwelling adults. This is particularly relevant because vitamin D's putative role in fall prevention via muscle function and neuromuscular coordination has long been used to justify supplementation even in people without frank deficiency.

The meta-analysis found no convincing signal that vitamin D improved neuromuscular outcomes at a population level in this setting. Some earlier, smaller trials had suggested a benefit — those positive signals do not replicate cleanly in the larger pooled dataset.

Why might calcium and vitamin D not work here?

The baseline sufficiency problem

One likely explanation is that most community-dwelling older adults in the included trials were not actually deficient at baseline. Vitamin D supplementation trials that have enrolled populations with confirmed severe deficiency (serum 25-hydroxyvitamin D below 25 nmol/L) have generally found larger benefits than those enrolling the general community, where average levels are higher LeBoff 2022. Supplementing a person who already has adequate stores is unlikely to produce measurable skeletal benefit — you cannot meaningfully "top up" a full tank.

The same logic applies to calcium. Most people living independently and consuming a reasonably varied diet already meet or approach the recommended dietary intake of 1,000–1,200 mg per day Weaver 2016. Adding a supplement on top of adequate dietary calcium may not move the needle on bone mineral density in a meaningful way.

Bone density is not the same as fracture risk

There is a conceptual sleight of hand in much of the older literature. Calcium and vitamin D demonstrably affect bone mineral density (BMD) in some populations — and BMD is correlated with fracture risk. But improving a surrogate marker does not automatically translate into preventing the outcome that actually matters to patients. A 2017 JAMA meta-analysis by Zhao and colleagues reached a similar conclusion: calcium supplementation modestly improved BMD but did not translate into reduced fracture rates in healthy older adults Zhao 2017. The 2026 Massé analysis is a larger, more comprehensive replication of that finding.

Falls have multiple causes beyond bone and muscle chemistry

Fall risk in older adults is genuinely multifactorial. It involves vision, medication side effects, home hazards, footwear, cardiovascular fitness, and neuromuscular co-ordination. Targeting one biochemical input — serum vitamin D — in a population that is not severely depleted is unlikely to overcome the aggregate of environmental and physiological contributors to falling. Multifactorial fall-prevention programmes that address balance training, medication review, and environmental hazards have considerably stronger evidence for reducing falls than supplementation alone Gillespie 2012.

What the evidence does not say

It would be a mistake to read this meta-analysis as a blanket verdict against all calcium and vitamin D supplementation. The study's finding applies most clearly to community-dwelling older adults without confirmed deficiency — and that caveat matters.

Residential care and frailty. A substantial body of evidence suggests that people living in care facilities, who are typically older, frailer, and spend less time outdoors, have much higher rates of severe vitamin D deficiency. In this population, supplementation trials have shown more consistent benefit, and clinical guidelines generally continue to recommend supplementation for institutionalised older adults.

Confirmed deficiency. If a person has laboratory-confirmed vitamin D deficiency (typically defined as serum 25-OH vitamin D below 50 nmol/L), treating that deficiency remains appropriate — not primarily to reduce fractures, but because severe deficiency causes osteomalacia, bone pain, and muscle weakness that are independently harmful.

Calcium absorption disorders. People with coeliac disease, inflammatory bowel disease, gastric bypass surgery, or other conditions affecting calcium absorption are a separate population from healthy community dwellers. The meta-analysis does not address these higher-risk clinical groups.

Children and younger adults. The review enrolled adults aged 50 and older. The evidence base for bone development in children and peak bone mass in young adults is different, and this meta-analysis says nothing about supplementation in those age groups.

What about the harms?

The meta-analysis also found evidence of potential harms with calcium supplementation that deserve attention. Higher-dose calcium supplements have been associated in some trials with elevated risk of kidney stones and, more controversially, cardiovascular events. A 2010 BMJ analysis by Bolland and colleagues raised concerns about myocardial infarction risk with calcium supplements not accompanied by vitamin D Bolland 2010. While the cardiovascular findings remain debated, the kidney stone signal is more consistent. In a population where the fracture-prevention benefit is negligible, the risk-benefit calculation shifts unfavourably.

This is important context. If the supplements were confirmed to prevent fractures, moderate kidney stone risk might be an acceptable trade-off for many patients. When the benefit disappears from the evidence, the harm side of the ledger becomes more significant.

What should you actually do about this?

If you are a healthy older adult living independently and you have been taking calcium and/or vitamin D supplements based on general advice rather than a confirmed deficiency or a specific medical indication, this meta-analysis is a reasonable prompt to have a conversation with your GP or pharmacist. The question to ask is not "should I stop immediately?" but "do I have a specific reason to take this, beyond routine supplementation?"

For most people, the honest answer may be that the supplement was started based on population-level advice that the evidence no longer supports at the same level of confidence. Stopping a supplement with no confirmed individual benefit and some potential for harm (particularly at higher calcium doses) is a defensible clinical decision in consultation with your care provider.

Dietary calcium and vitamin D — from food, sunlight exposure, and genuine clinical need — remain important. The research challenge is that most people misread supplement trials as though they confirm a universal benefit, when the benefit is consistently modest, context-dependent, and in this case, absent in the population most likely to be taking them.

Practical takeaways

References

Massé 2026Massé O et al. Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis. BMJ. 2026. PMID 42161415. View source →
Abrahamsen 2009Abrahamsen B et al. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20(10):1633–1650. PMID 19421703. View source →
Parkkari 1999Parkkari J et al. Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur. Calcif Tissue Int. 1999;65(3):183–187. PMID 10441647. View source →
LeBoff 2022LeBoff MS, Chou SH, Ratliff KA, et al. Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. N Engl J Med. 2022;387(4):299–309. PMID 35939577. View source →
Weaver 2016Weaver CM et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016;27(1):367–376. PMID 26510847. View source →
Zhao 2017Zhao JG, Zeng XT, Wang J, Liu L. Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis. JAMA. 2017;318(24):2466–2482. PMID 29279934. View source →
Gillespie 2012Gillespie LD et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012;(9):CD007146. PMID 22972103. View source →
Bolland 2010Bolland MJ et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691. PMID 20671013. View source →
Watson 2018Watson SL et al. High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial. J Bone Miner Res. 2018;33(2):211–220. PMID 28975661. View source →

Related reading

The strength-training sweet spot for a longer lifeLongevity

The strength-training sweet spot for a longer life

DHA Reached the Brain — and Still Did NothingBrain Health

DHA Reached the Brain — and Still Did Nothing

Creatine: what the science actually showsSupplements

Creatine: what the science actually shows